Medicina y Especialidades Médicas
Departamento
University of Texas MD Anderson Cancer Center
Houston, Estados Unidos
Publicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (2)
2025
- Vodobatinib for patients with Philadelphia chromosome-positive chronic myeloid leukaemia resistant or intolerant to multiple lines of previous therapy: an open-label, multicentre, phase 1/2 trial
The Lancet Haematology, Vol. 12, Núm. 3, pp. e201-e213
